Testing effectiveness (Phase 2)Study completedNCT04139057
What this trial is testing
EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC
Who this might be right for
Head and Neck Squamous Cell Carcinoma
Xinqiao Hospital of Chongqing 10